Sandbox Reserved 911: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 4: Line 4:
<StructureSection load='2VYA' size='350' frame='true' align='right' caption='Fatty Acid Amide Hydrolase 1' scene='57/573125/2vya/1'>
<StructureSection load='2VYA' size='350' frame='true' align='right' caption='Fatty Acid Amide Hydrolase 1' scene='57/573125/2vya/1'>
==Introduction==
==Introduction==
Fatty acid amide hydrolase (FAAH) degrades fatty acid amides to terminate their signaling activity.(IMT5) A serine hydrolase from the [http://en.wikipedia.org/wiki/Amidase Amidase] signature superfamily of enzymes ([http://proteopedia.org/wiki/index.php/Category:Amidase other amidases]), FAAH degrades endocannabinoid signaling lipids, molecules associated with pain relief.(2VYA) Because [http://en.wikipedia.org/wiki/Endocannabinoid_system endocannabinoids] are lipid molecules, they cannot be compartmentalized in vesicles (the degradation method for other neurotransmitters) and must instead be degraded in the bilayer of the cell membrane. FAAH is an integral membrane protein that degrades FAAs as they enter the membrane bilayer. (IMT5) Current research about FAAH aims to find inhibitors for the enzyme, which would prolong the pain alleviation provided by endocannabinoid molecules. (2VYA)
Fatty acid amide hydrolase (FAAH) degrades fatty acid amides to terminate their signaling activity.(IMT5) A serine hydrolase from the [http://en.wikipedia.org/wiki/Amidase Amidase] signature superfamily of enzymes ([http://proteopedia.org/wiki/index.php/Category:Amidase other amidases]), FAAH degrades endocannabinoid signaling lipids, molecules associated with pain relief.(2VYA) Because [http://en.wikipedia.org/wiki/Endocannabinoid_system endocannabinoids] are lipid molecules, they cannot be compartmentalized in vesicles (the degradation method for other neurotransmitters) and must instead be degraded in the bilayer of the cell membrane. FAAH is an integral membrane protein that degrades FAAs as they enter the membrane bilayer, allowing the cell to terminate the activity of signaling molecules that cannot be contained within a vesicle for degredation. (IMT5) Current FAAH research aims to find inhibitors for the enzyme, which would prolong the pain alleviation provided by endocannabinoid molecules. (2VYA)


[[Image:1MT5.png|400 px|left|thumb|FAAH Subunit]]
[[Image:1MT5.png|400 px|left|thumb|FAAH Subunit]]